Increased serum IL-10/IL-12 ratio in wheezing infants

Pediatric Allergy and Immunology

Volumn 14, Issue 2, 2003, Pages 112-119

  Koopman, Laurens P ^a   Savelkoul, Huub ^b   Van Benten, Inesz J ^c   Gerritsen, Jorrit ^d   Brunekreef, Bert ^e   Neijens, Herman J ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

^e UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Atopic; Dermatitis; IL 10; IL 12; Infant; Serum markers; Wheezing

Indexed keywords

BIOLOGICAL MARKER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EOTAXIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 2 RECEPTOR;

ALLERGY; ARTICLE; ASTHMA; ATOPIC DERMATITIS; ATOPY; BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE RELEASE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; RASH; WHEEZING;

BIOLOGICAL MARKERS; CHILD, PRESCHOOL; EXANTHEMA; FEMALE; HUMANS; INFANT; INTERLEUKIN-10; INTERLEUKIN-12; MALE; RESPIRATORY SOUNDS;

EID: 0037677636     PISSN: 09056157     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3038.2003.00019.x     Document Type: Article

References (39)

1. WILLIAMS HC, FORSDYKE H, BOODOO G, HAY RJ, BURNEY PG. A protocol for recording the sign of flexural dermatitis in children. Br J Dermatol 1995: 133: 941-9.
2. MARTINEZ FD. Recognizing early asthma. Allergy 1999: 54: 24-8.
3. LEUNG DY. Pathogenesis of atopic dermatitis. J Allergy Clin Immunol 1999: 104: S99-108.
4. KAY AB. Allergy and allergic diseases. First of two parts. N Engl J Med 2001: 344: 30-7.
5. LAAN MP, BAERT MR, BIJL AM, et al. Markers for early sensitization and inflammation in relation to clinical manifestations of atopic disease up to 2 years of age in 133 high-risk children. Clin Exp Allergy 2000: 30: 944-53.
6. SINIGAGLIA F, D'AMBROSIO D. Regulation of helper T cell differentiation and recruitment in airway inflammation. Am J Respir Crit Care Med 2000: 162: S 157-60.
7. BARNES PJ, Lim S. Inhibitory cytokines in asthma. Mol Med Today 1998: 4: 452-8.
8. BUSSE WW, LEMANSKE RF Jr. Asthma. N Engl J Med 2001: 344: 350-62.
9. BOCHNER BS. Cellular adhesion and its antagonism. J Allergy Clin Immunol 1997: 100: 581-5.
10. MATSUMOTO T, MIIKE T, YAMAGUCHI K, MURAKAMI M, KAWABE T, YODOI J. Serum levels of soluble IL-2 receptor, IL-4 and IgE-binding factors in childhood allergic diseases. Clin Exp Immunol 1991: 85: 288-92.
11. WIJGA A, SMIT HA, BRUNEKREEF B, et al. Are children at high familial risk of developing allergy born into a low risk environment? The PIAMA Birth Cohort Study. Prevention and incidence asthma mite allergy. Clin Exp Allergy 2001: 31: 576-81.
12. KOOPMAN LP, VAN BENTEN IJ, DE WAAL L, FOKKENS WJ, OSTERHAUS ADME, NEIJENS HJ. Virus mediated allergy (VIGALL)-study: Study design and clinical results 1 year follow-up. Am J Respir Crit Care Med 2000: 161: A347.
13. ASHER MI, KEIL U, ANDERSON HR, et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J 1995: 8: 483-91.
14. LAKWIJK N, VAN STRIEN RT, DOEKES G, BRUNEKREEF B, GERRITSEN J. Validation of a screening questionnaire for atopy with serum IgE tests in a population of pregnant Dutch women. Clin Exp Allergy 1998: 28: 454-8.
15. STALLMAN PJ, WAGENAAR S, SWIERENGA J, VAN DER WAL RJ, FELTKAMP-VROOM TM. Cell-bound IgE on human mast cells and basophilic granulocytes in atopic and nonatopic subjects. Int Arch Allergy Appl Immunol 1977: 54: 443-50.
16. SCHUURMAN J, PERDOK GJ, LOURENS TE, PARREN PW, CHAPMAN MD, AALBERSE RC. Production of a mouse/human chimeric IgE monoclonal antibody to the house dust mite allergen Der p 2 and its use for the absolute quantification of allergen-specific IgE. J Allergy Clin Immunol 1997: 99: 545-50.
17. TRINCHIERI G. Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994: 84: 4008-27.
18. WILLS-KARP M. IL-12/IL-13 axis in allergic asthma. J Allergy Clin Immunol 2001: 107: 9-18.
19. MEYAARD L, HOVENKAMP E, OTTO SA, MIEDEMA F. IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses. J Immunol 1996: 156: 2776-82.
20. NASEER T, MINSHALL EM, LEUNG DY, et al. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy. Am J Respir Crit Care Med 1997: 155: 845-51.
21. CHOU CC, HUANG MS, HSIEH KH, CHIANG BL. Reduced IL-12 level correlates with decreased IFN-gamma secreting T cells but not natural killer cell activity in asthmatic children. Ann Allergy Asthma Immunol 1999: 82: 479-84.
22. D'ANDREA A, ASTE-AMEZAGA M, VALIANTE NM, MA X, KUBIN M, TRINCHIERI G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993: 178: 1041-8.
23. OHMEN JD, HANIFIN JM, NICKOLOFF BJ, et al. Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions. J Immunol 1995: 154: 1956-63.
24. NIWA Y, AKAMATSU H, SUMI H, OZAKI Y, ABE A. Evidence for degradation of cytokines in the serum of patients with atopic dermatitis by calcium-dependent protease. Arch Dermatol Res 2000: 292: 391-6.
25. BONT L, HEIJNEN CJ, KAVELAARS A, et al. Monocyte IL-10 production during respiratory syncytial virus bronchiolitis is associated with recurrent wheezing in a one-year follow-up study. Am J Respir Crit Care Med 2000: 161: 1518-23.
26. MOSMANN TR, MOORE KW. The role of IL-10 in crossregulation of TH1 and TH2 responses. Immunol Today 1991: 12: A49-53.
27. KOULIS A, ROBINSON DS. The anti-inflammatory effects of interleukin-10 in allergic disease. Clin Exp Allergy 2000: 30: 747-50.
28. PRETOLANI M. Interleukin-10: An anti-inflammatory cytokine with therapeutic potential. Clin Exp Allergy 1999: 29: 1164-71.
29. MARTINEZ FD, WRIGHT AL, TAUSSIG LM, HOLBERG CJ, HALONEN M, MORGAN WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995: 332: 133-8.
30. BLANCO-QUIROS A, GONZALEZ H, ARRANZ E, LAPENA S. Decreased interleukin-12 levels in umbilical cord blood in children who developed acute bronchiolitis. Pediatr Pulmonol 1999: 28: 175-80.
31. BALL TM, CASTRO-RODRIGUEZ JA, GRIFFITH KA, HOLBERG CJ, MARTINEZ FD, WRIGHT AL. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. N Engl J Med 2000: 343: 538-43.
32. KIMATA H. Increased serum levels of soluble adhesion molecules in young children with atopic dermatitis. Eur J Pediatr 1999: 158: 529-30.
33. YAMASHITA N, KANEKO S, KOURO O, FURUE M, YAMAMOTO S, SAKANE T. Soluble E-selectin as a marker of disease activity in atopic dermatitis. J Allergy Clin Immunol 1997: 99: 410-6.
34. LAAN MP, KONING H, BAERT MR, et al. Levels of soluble intercellular adhesion molecule-1, soluble E-selectin, tumor necrosis factor-alpha, and soluble tumor necrosis factor receptor p55 and p75 in atopic children. Allergy 1998: 53: 51-8.
35. RIISE GC, LARSSON S, LOWHAGEN O, ANDERSSON BA. Circulating leukocyte adhesion molecules in stable asthma and nonobstructive chronic bronchitis. Allergy 1995: 50: 693-8.
36. WOLKERSTORFER A, LAAN MP, SAVELKOUL HF, et al. Soluble E-selectin, other markers of inflammation and disease severity in children with atopic dermatitis. Br J Dermatol 1998: 138: 431-5.
37. SHI HZ, SUN JJ, PAN HL, LU JQ, ZHANG JL, JIANG JD. Alterations of T-lymphocyte subsets, soluble IL-2 receptor, and IgE in peripheral blood of children with acute asthma attacks. J Allergy Clin Immunol 1999: 103: 388-94.
38. MILLER AL, STERN DA, MARTINEZ FD, WRIGHT AL, TAUSSIG LM, HALONEN M. Serum levels of the soluble low affinity receptor for IgE and soluble interleukin-2 receptor in childhood, and their relation to age, gender, atopy and allergic disease. Pediatr Allergy Immunol 1996: 7: 68-74.
39. LANZ MJ, LEUNG DY, MCCORMICK DR, HARBECK R, SZEFLER SJ, WHITE CW. Comparison of exhaled nitric oxide, serum eosinophilic cationic protein, and soluble interleukin-2 receptor in exacerbations of pediatric asthma. Pediatr Pulmonol 1997: 24: 305-11.